Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Pfizer (PFE) Pushes Higher after Ending Allergan Deal; Shares Cross Above 200 DMA
April 6, 2016 12:35 PM EDTPfizer (NYSE: PFE) is adding to early gains after terminating the deal to acquire Allergan and shares just crossed about its 200 day moving average on high volume. Shares last traded up 3.7% to $32.53.
... More